Cytokinetics
CYTK
CYTK
134 hedge funds and large institutions have $502M invested in Cytokinetics in 2019 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 70 increasing their positions, 23 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
3% less funds holding
Funds holding: 138 → 134 (-4)
11% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 18
Holders
134
Holding in Top 10
3
Calls
$7.07M
Puts
$917K
Top Buyers
| 1 | +$24.6M | |
| 2 | +$15.5M | |
| 3 | +$11.7M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$6.83M |
| 5 |
State Street
Boston,
Massachusetts
|
+$4.21M |
Top Sellers
| 1 | -$11.8M | |
| 2 | -$2.9M | |
| 3 | -$1.92M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.78M |
| 5 |
Goldman Sachs
New York
|
-$1.51M |